Zobrazeno 1 - 10
of 196
pro vyhledávání: '"J M Cuisset"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nathalie Goemans, Eugenio Mercuri, Elena Belousova, Hirofumi Komaki, Alberto Dubrovsky, Craig M. McDonald, John E. Kraus, Afrodite Lourbakos, Zhengning Lin, Giles Campion, Susanne X. Wang, Craig Campbell, A. Araujo, E. Bertini, P. Born, C. Cances, B. Chabrol, J.-H. Chae, J. Colomer Oferil, G.P. Comi, J.-M. Cuisset, G. D'Anjou, I. Desguerre, R. Erazo Torricelli, R. Escobar, D. Feder, A. Ferlini, R. Giugliani, E. Henricson, A. Herczegfalvi, Y.-J. Jong, S. Kimura, J.-B. Kirschner, K. Kleinsteuber, A. Kostera-Pruszczyk, M. Kudr, W. Mueller-Felber, E.H. Niks, K. Ogata, C. Palermo, M. Pane, I. Pascual, Y. Pereon, S. Raskin, M. Rasmussen, U. Reed, U. Schara, K. Selby, C. Sobreira, Y. Takeshima, J.J. Vilchez Padilla, G. Vita, P. Vondracek, G. Wiegand, E. Wilichowski
Publikováno v:
Paediatrics Publications
Neuromuscular Disorders
Neuromuscular Disorders, 28(1), 4-15
Neuromuscular Disorders
Neuromuscular Disorders, 28(1), 4-15
This 48-week, randomized, placebo-controlled phase 3 study (DMD114044; NCT01254019) evaluated efficacy and safety of subcutaneous drisapersen 6 mg/kg/week in 186 ambulant boys aged >=5 years, with Duchenne muscular dystrophy (DMD) resulting from an e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J-M, Cuisset, F, Rivier
Publikováno v:
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 22(12 Suppl 1)
The dystrophin gene involved in Duchenne and Becker muscular dystrophy is expressed in three main tissues resulting in clinical manifestations: skeletal muscle, heart and central nervous system. The 6 different existing dystrophins in the brain may p
Autor:
B. Estournet, J.-M. Cuisset
Publikováno v:
Revue Neurologique. 168:902-909
Typical childhood spinal muscular atrophy is a disease that affects the anterior horn of the spinal cord related to SMN1 gene defects. Since no etiological treatment is currently available, its management is necessarily symptomatic and involves multi
Autor:
L. Vallée, Claude-Alain Maurage, Bruno Bastide, Caroline Cieniewski-Bernard, J. M. Cuisset, Yvonne Mounier, Erwan Dupont, Laurence Stevens, Valérie Montel
Publikováno v:
Neuropathology and Applied Neurobiology. 34:659-670
Aims: Although modifications of the survival motor neurone gene are responsible for most spinal muscular atrophy (SMA) cases, the molecular pathophysiology and the muscular target proteins involved are still unknown. The aim of this study was to comp
Publikováno v:
Neuropsychiatrie de l'Enfance et de l'Adolescence. 56:58-62
Resume Le but de cet article est de presenter une conception en reseau de la prise en charge de soutien et d’accompagnement de l’enfant atteint d’une maladie neuromusculaire et de ses parents. Face au risque de clivage entre le somatique et le
Publikováno v:
Annales de Réadaptation et de Médecine Physique. 50:645-650
UNLABELLED Respiratory muscle weakness associated with scoliosis in neuromuscular disease leads to respiratory impairment. Children with scoliosis are usually treated with spinal bracing to delay the progress of disease. We studied the impact of spin
Autor:
R, Cremer, C, Lervat, A, Laffargue, J, Le Cunff, S, Joriot, C, Minnaert, J-M, Cuisset, K, Mention, D, Thomas, D, Guimber, A, Matthews, P, Fayoux, L, Storme, S, Vandoolaeghe, Sylvie, Vandoolaeghe
Publikováno v:
Archives de Pédiatrie
Archives de Pédiatrie, Elsevier, 2015, 22 (11), pp.1119-1128. ⟨10.1016/j.arcped.2015.08.004⟩
Archives de Pédiatrie, 2015, 22 (11), pp.1119-1128. ⟨10.1016/j.arcped.2015.08.004⟩
Archives de Pédiatrie, Elsevier, 2015, 22 (11), pp.1119-1128. ⟨10.1016/j.arcped.2015.08.004⟩
Archives de Pédiatrie, 2015, 22 (11), pp.1119-1128. ⟨10.1016/j.arcped.2015.08.004⟩
International audience; In 2005, the French law on patients’ rights at the end of life required that decisions to withdraw or withhold life-sustaining treatments be made and carried out by the physician in charge of the patient, after obtaining adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0497ac3f72b99344b165238a92f019e5
https://hal.archives-ouvertes.fr/hal-01339001/file/Collegialite.pdf
https://hal.archives-ouvertes.fr/hal-01339001/file/Collegialite.pdf
Publikováno v:
European journal of physical and rehabilitation medicine. 51(3)
In a 12-year old girl suffering from autosomal recessive axonal Charcot-Marie-Tooth (CMT) neuropathy, pes cavovarus was treated with botulinum toxin injection in the tibialis posterior. The patient underwent a clinical evaluation, video analysis of s